Skip to content
Screener

SI-BONE, Inc. SIBN EPS (Diluted)

EPS (Diluted) at other companies

Stryker logo
StrykerSYK
$3.30+44.1%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.03+33.8%
Globus Medical logo
Globus MedicalGMED
$1.10-26.2%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$0.22+37.1%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
-$0.07-450%
Medtronic logo
MedtronicMDT
$0.97+18.3%

Other financials

Income statement

See full
Revenue$52.6M+11.2%
Gross profit$41.9M+11.3%
Operating income-$5.1M+31.9%
Net income-$4.3M+33.8%

Balance sheet

See full
Cash & equivalents$33.5M-18.6%
Total debt$42.9M+15.6%
Total equity$178.9M+7.0%
Total assets$242.7M+6.8%

Cash flow

See full
Operating cash flow-$2.4M+51.9%
CapEx$1.1M-48.0%
Free cash flow-$3.4M+50.8%

Valuation

See full
Market cap$834.07M+25.5%
Enterprise value$843.49M+26.4%
P/S+0.5×

Profitability

See full
Gross margin79.6%+0.3pp
Operating margin-9.7%-3.0pp
Net margin-8.1%-2.6pp
FCF margin-2.9%-1.2pp

Returns & leverage

See full
Return on equity-9.6%-2.7pp
Debt / equity0.2×0.0×
Current ratio10×+1.5×

Where this comes from

Reported directly by SI-BONE, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: SI-BONE, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:03 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001459839-26-000056
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense)18
Net loss$(4,334)$(6,542)
Other comprehensive income (loss):
Changes in foreign currency translation(160)157
Unrealized loss on marketable securities(155)(81)
Comprehensive loss$(4,649)$(6,466)
Net loss per share, basic and diluted$(0.10)$(0.15)
Weighted-average number of common shares used to compute basic and diluted net loss per share43,959,76042,337,481

Item 1. Financial Statements

FAQ

What is SI-BONE, Inc.'s EPS (diluted)?
SI-BONE, Inc. (SIBN) reported EPS (diluted) of -$0.10 in Q1 2026.
How has SI-BONE, Inc.'s EPS (diluted) changed year-over-year?
SI-BONE, Inc.'s EPS (diluted) increased by 33.3% year-over-year, from -$0.15 to -$0.10.
What is the long-term trend for SI-BONE, Inc.'s EPS (diluted)?
Over 4 years (2021 to 2025), SI-BONE, Inc.'s EPS (diluted) has grown at a -28.7% compound annual growth rate (CAGR), from -$1.70 to -$0.44.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about SI-BONE, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude